The frequentist versus Bayesian debate has been running in statistics departments for over a century. For most of that time, it was genuinely philosophical — competing views about what probability means and what inference should achieve. For A/B testers in 2025, though, the difference is almost entirely practical. It determines how you read results, whether you can peek at ongoing tests, and how long experiments have to run before you can act on them.
Neither approach is universally correct. Both make tradeoffs. But understanding those tradeoffs precisely — not in the abstract, but in the context of running experiments on your product — is the difference between a testing program that accelerates decisions and one that creates bottlenecks.
What frequentist testing actually produces
The output of a frequentist A/B test is a p-value and a confidence interval. The p-value answers a specific question: if the null hypothesis were true (i.e., there is no real difference between the variants), what is the probability of observing data at least as extreme as what we got?
Notice what that question does not ask. It does not ask how probable it is that variant B is better than variant A. It does not tell you how large the effect probably is. It does not give you the probability that your test result is a real signal versus noise. It answers a narrower, more indirect question about the behavior of a hypothetical repeated experiment under a false null.
This is not a flaw — it is what the method was designed to do, which was to provide decision rules that control long-run error rates across many experiments. If you use p < 0.05 as your threshold across thousands of tests on truly null effects, you will make false-positive decisions about 5% of the time. That guarantee is real and mathematically sound.
The problem for teams running a modest number of experiments per month is that the guarantee is about long-run behavior across many tests, not about the specific test in front of you. A single p-value of 0.04 does not mean there is a 96% chance the effect is real. It means the data would be unlikely if there were no effect. Those are different statements.
What Bayesian testing produces instead
A Bayesian A/B test produces a posterior probability distribution — a statement about what the data tells you about the likely range of the true effect. The most commonly cited output is something like: "there is a 94.2% probability that variant B has a higher conversion rate than variant A."
That statement is interpretable in plain language. It says what it means. You can use it to make a decision directly: if the posterior probability exceeds your business threshold (say, 95%), call the test. If it does not, run it longer or accept uncertainty.
The catch is that Bayesian results depend on a prior — an initial assumption about the distribution of plausible effect sizes before the data arrives. In A/B testing, a common prior is weakly informative: centered at zero effect, with moderate variance. This reflects genuine uncertainty about the outcome. As data accumulates, the prior is updated according to Bayes' rule, and the posterior converges on the true effect as sample size grows.
With a weakly informative prior on a large dataset, Bayesian and frequentist methods produce very similar answers. The practical differences emerge at small sample sizes (where the prior matters more) and when you need to make interim decisions (where the two methods have fundamentally different properties).
The peeking problem: where the methods diverge most
The most operationally significant difference between the two approaches is how they handle interim analysis — checking results before the prespecified sample size is reached.
In frequentist testing, peeking inflates false-positive rates. If you check at 50% of your target sample and stop early if p < 0.05, then check again at 100%, your overall false-positive rate is roughly 8-9% rather than 5%. Check at 25%, 50%, 75%, and 100%, and it climbs higher. The mathematical guarantee breaks down because the guarantee was conditional on checking exactly once.
Sequential frequentist methods exist that allow interim looks with maintained error rates — group sequential testing, alpha spending functions. These work by allocating the "alpha budget" across planned interim analyses. But they require specifying the number of looks and the allocation rule in advance, and they reduce statistical power relative to a single-look test.
Bayesian methods handle interim analysis differently. Because the posterior probability is continuously updated, checking it at any point is statistically coherent. There is no peeking problem in the frequentist sense. You can monitor the dashboard every day without distorting the long-run behavior of the analysis. The decision rule — stop when posterior probability exceeds threshold — remains valid whether you apply it after 500 observations or 5,000.
This property is commercially valuable. Teams do not actually wait passively for tests to complete. They watch dashboards. They face questions from stakeholders. Bayesian methods are designed for that reality; frequentist methods require discipline to avoid it.
Practical differences in stopping time
For a test with a large true effect, Bayesian methods typically require fewer observations to reach a decision. The posterior probability accumulates faster when the effect is large and consistent. This can reduce test duration by 25-45% compared to fixed-horizon frequentist tests targeting equivalent power.
For a test with a small or noisy true effect, Bayesian methods may require more observations, because the posterior takes longer to move decisively. This is correct behavior — the evidence is weaker, and the decision should require more data. Fixed-horizon tests with pre-set sample sizes can declare significance on small, noisy effects that do not replicate, because they did not ask "is this evidence strong enough?" — they asked "does this exceed my threshold?"
In practice, Bayesian stopping tends to be well-calibrated: tests end when the data actually supports a decision, rather than when an arbitrary sample size target is reached. For teams that have experienced the disappointment of "statistically significant" results that failed to replicate, this is a meaningful change.
When frequentist methods remain the right choice
Bayesian testing is not appropriate for every situation. Frequentist methods remain preferable in several scenarios:
Regulatory contexts where reproducible decision rules with defined error rates are required — pharmaceutical trials, financial stress testing, quality control in manufacturing. These fields chose frequentist methods for good reasons related to auditability and long-run guarantees.
Situations where you need to estimate the exact magnitude of an effect with calibrated uncertainty — not just which variant wins, but by how much, with a confidence interval that can be directly communicated to stakeholders or used in further modeling. Frequentist confidence intervals have stricter coverage guarantees under repeated sampling.
Very high-traffic, high-stakes tests where prior beliefs should not influence the result. A frequentist test on a hundred thousand observations is essentially insensitive to the prior, and the added complexity of choosing a prior is unnecessary overhead.
How to read a Bayesian dashboard in practice
If you switch to a Bayesian testing platform, the outputs change in ways that require adjustment. A few things to know:
The "probability to be best" metric is not a p-value inverted. A 93% probability that variant B wins is not equivalent to p = 0.07. They are answering different questions. Do not apply frequentist interpretation rules to Bayesian outputs.
Expected loss is a useful companion metric. It answers: if you make the wrong decision (stop and call variant B the winner when it is actually worse), how much expected revenue do you lose? Setting a minimum runtime to keep expected loss below a threshold is often better than a pure probability cutoff.
The posterior distribution is more informative than a single probability number. If variant B's posterior distribution of conversion rate uplift spans -0.1% to +4.2%, the central estimate might be +1.8% — but the full distribution tells you there is meaningful probability of a small negative effect. A single probability number hides that.
Making the decision for your team
The right method depends on what your team needs to do with test results. If you are running high-volume tests where statistical rigor and reproducibility are paramount, and you have the discipline to pre-commit to sample sizes and not peek, frequentist methods with proper power calculations work well.
If you are a growth team running 5-15 experiments per month, facing commercial pressure to make decisions before tests are formally complete, and want results you can interpret without a statistics background, Bayesian methods are operationally better suited.
Most companies running A/B tests in 2025 are in the second category. The shift to Bayesian testing is partly about statistical correctness and partly about designing a system that works with how teams actually behave under pressure — not how statisticians assume they should.
Webyn's testing engine uses Bayesian updating with interpretable probability outputs. You see the chance of winning as data arrives, not after a fixed wait. Request a demo to see it in action.